SOS1

CAT # Izina ryibicuruzwa Ibisobanuro
CPD10000 BI-3406 BI-3406 ni Imbaraga & Guhitamo SOS1 :: Inhibitor ya KRAS (IC50 = 5 nM), ifungura uburyo bushya bwo kuvura ibibyimba biterwa na KRAS. BI 3406 ihitamo guhuza SOS1 ikanahagarika imikoranire na KRAS, hatitawe ku ihinduka rya KRAS. BI 3406 itera RAS GTP na pERK igabanya kandi ikabuza gukura kwingirabuzimafatizo ya KRAS ihindagurika ryimikorere, itwara ibyinshi mubisanzwe byahinduwe na KRAS (ni ukuvuga G12D, G12V, G13D nibindi). BI 3406, iyo itanzwe kumunwa kumbeba zifite imbeba, itera ingaruka ziterwa nibibyimba bihamye bishobora guhinduka mugusubira inyuma iyo bihujwe na MEK1 kubuza.
CPD2807 BAY-293 BAY-293 ninzitizi ikomeye ya SOS1 ibuza gukora RAS binyuze mu guhagarika imikoranire ya RAS-SOS1. BAY-293) ihitamo guhitamo imikoranire ya KRAS-SOS1 na IC50 ya 21 nM kandi ni iperereza ryimiti ryiperereza ryigihe kizaza.
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!